SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)

Clinical trial NCT00102739 · COMPLETED

Trial details

NCT number: NCT00102739
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Purpura, Thrombocytopaenic, Idiopathic

Start date: 2005-02-01
Primary completion: 2007-01-01
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.